Lewis Thomas

Medicine & Life Sciences

1. Urinary Bladder Neoplasms 100%
2. Cystectomy 75%
3. Bacillus 50%
4. Urinary Diversion 43%
5. Docetaxel 38%
6. gemcitabine 38%
7. Robotics 35%
8. Prostatic Neoplasms 33%
9. Salvage Therapy 31%
10. Mycobacterium bovis 29%
11. Prostatectomy 29%
12. Interferons 27%
13. Prostate 25%
14. Treatment Failure 19%
15. Survival 18%
16. Immunotherapy 18%
17. Obesity 17%
18. Recurrence 17%
19. Interferon-alpha2b 16%
20. Therapeutics 15%
21. Renal Cell Carcinoma 14%
22. Urinary Bladder 14%
23. Kidney 13%
24. Drug Therapy 13%
25. Giardiasis 11%
26. Watchful Waiting 11%
27. Nephrolithiasis 11%
28. Neurogenic Urinary Bladder 11%
29. Neoplasms 10%
30. Prostatitis 10%
31. Neoplasm Metastasis 10%
32. Dihydrotestosterone 10%
33. Pathologic Constriction 10%
34. Carcinoma, Intraductal, Noninfiltrating 10%
35. Germ Cell and Embryonal Neoplasms 10%
36. Mortality 9%
37. Combination Drug Therapy 9%
38. Urodynamics 9%
39. Anorexia Nervosa 9%
40. Kidney Neoplasms 9%
41. Granulocyte-Macrophage Colony-Stimulating Factor 8%
42. Mycoses 8%
43. Waist Circumference 8%
44. Urinary Tract Infections 8%
45. Cohort Studies 7%
46. Testis 7%
47. Interleukin-2 7%
48. Pathology 7%
49. Body Mass Index 7%
50. Conflict of Interest 7%